Triple agonist peptide widely referenced in current metabolic research literature.
| Purity | ≥99.3% |
| Category | Metabolic |
| Available Sizes | 5mg, 10mg |
| Batch Number | #NZP-RET-0452 |
| Last Tested | 20 Aug 2026 |
| Storage | Store lyophilised vial at -20°C, protect from light |
Batch #NZP-RET-0452 · Independently tested 20 Aug 2026
Retatrutide is a triple receptor agonist peptide that has rapidly become one of the most widely referenced compounds in current metabolic research literature. Our most requested product, it reflects significant ongoing research interest in multi-receptor metabolic pathways. Supplied strictly for laboratory research use, with every batch independently lab tested.
Every peptide we stock is manufactured under strict quality control and independently verified by a third-party New Zealand laboratory before release. Each vial is single-use, tamper-sealed, and shipped with a batch-matched Certificate of Analysis confirming identity and purity.
This product is sold strictly for laboratory and in-vitro research purposes. It is not a drug, food, cosmetic, or dietary supplement, and is not intended for human or animal consumption, diagnostic, or therapeutic use. By purchasing this product you confirm that you are a qualified researcher and agree to our full research use disclaimer.
You May Also Need
Other research compounds frequently ordered alongside Retatrutide.
Mitochondrial-derived peptide of interest in metabolic regulation research.
Pentadecapeptide widely studied in tissue repair and recovery research models.
Growth-hormone releasing factor analogue used in metabolic research studies.
Chat to our team directly on WhatsApp — we usually reply within minutes.